No Data
*Special Treat Aonong (603363.SH): Applying to revoke the delisted risk warning and continue to be subjected to the delisted risk warning and other risk warnings.
Gelonghui reported on December 27 that *ST Fujian Aonong Biological Technology Group Incorporation (603363.SH) announced that it received a "Civil Ruling" from the Intermediate People's Court of Zhangzhou, Fujian Province, which confirmed the completion of the "Reorganization Plan of Fujian Aonong Biological Technology Group Incorporation" and concluded the company's reorganization procedure. Recently, the administrator issued a "Supervision Report on the Implementation of Aonong Biological Reorganization Plan", and Beijing Zhonglun Law Firm provided a "Legal Opinion on the Completion of the Reorganization Plan of Fujian Aonong Biological Technology Group Incorporation". The delisting risk warning situation that the company faced due to the court's ruling for reorganization has ceased.
*Special Treat Aonong (603363.SH): After the restructuring, the consortium of industrial investors will become the controlling Shareholder.
*Special Treat Aonong (603363.SH) announced that after the restructuring plan is completed, the industry investor consortium will collectively...
*Special Treat Aonong (603363.SH): The company plans to change to having no actual controlling party.
On December 19, Gelonghui reported that *ST Aonong (603363.SH) announced that after the completion of the "Reorganization Plan" and "Aotou Reorganization Plan," the controlling shareholder of the company will change from Zhangzhou Aonong Investment Co., Ltd. (referred to as "Aonong Investment") to a consortium of investors in the company's reorganization, and the company will change to having no actual controller.
*Special Treat Aonong (603363.SH): Plans to dispose of Assets in the reorganization process.
On December 10, Gelonghui reported that *ST Aonong (603363.SH) announced that the court has ruled to approve the reorganization plan and terminate the company's reorganization process, entering the execution phase of the reorganization plan. According to the reorganization plan, the company will set up a trust plan to separate its assets, and the corresponding trust benefits will serve as one of the sources of the repayment resources required to settle ordinary debts exceeding 20 million. The company will first transfer the equity of its intended divested subsidiaries to Zhangzhou Xiangcheng Aoshun Technology Co., Ltd. and Xiamen Aonong Modern Agriculture Technology Co., Ltd. After completion, it will then transfer the 100% equity held in Xiamen Aonong Modern Agriculture Technology Co., Ltd.
Fujian Aonong Biotechnology Group Co., Ltd. announced the main operating data of the aquaculture business in November 2024
*Special treat Aonong (603363.SH) disclosed a reorganization plan draft, intending to increase capital reserve by converting 20 shares for every 10 shares.
*Special treat Fujian Aonong (603363.SH) has announced a restructuring plan (draft), based on the current total share capital of Aonong Biological (...)
Fujian Aonong Biological Technology Group Incorporation (SHSE:603363) Has Debt But No Earnings; Should You Worry?
